Related Experiment Video

Updated: Dec 23, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.2K

The economics of a pediatric surgical ICU

Bethany J Slater1, Adam M Vogel2

  • 1University of Chicago Medicine, Chicago, Illinois.

Current Opinion in Pediatrics
|April 26, 2020
PubMed

Insights

Specialized pediatric intensive care units (PICUs) improve outcomes and may reduce costs for critically ill surgical patients. Further research is needed to define quality measures for these complex care systems.

Area of Science:

  • Pediatric Surgery
  • Critical Care Medicine
  • Health Economics

Background:

  • Innovations in neonatology and pediatric surgical techniques have increased the number of complex postoperative patients.
  • Specialized pediatric centers demonstrate improved patient outcomes.
  • Evidence suggests financial benefits, including decreased costs and efficient resource utilization, in pediatric subspecialty critical care.

Purpose of the Study:

  • To outline quality and financial economic principles for complex care delivery systems.
  • To support the development of specialized intensive care units for critically ill pediatric surgical patients.

Main Methods:

  • This is a review article.
  • The review synthesizes existing literature on quality and economic principles in pediatric surgical critical care.

Main Results:

  • Specialized pediatric intensive care units (PICUs) have the potential to enhance the value of care for complex pediatric surgical patients.
  • Improved outcomes have been observed in specialized pediatric centers.
  • Potential financial benefits include reduced costs and more efficient resource allocation.

Conclusions:

  • Pediatric surgical critical care and specialized PICUs can improve the value of care for complex patients.
  • Further well-designed, prospective, observational studies are necessary to establish appropriate outcome and quality measures.
  • Collaborative, multidisciplinary efforts are crucial for developing and optimizing these specialized care models.
Abstract

More Related Videos

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.7K
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

5.7K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
149
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
177
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
222
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
133